Bachem brings peptide CMO offers to CPhI MEA
News | Bachem AG
SEPTEMBER 05, 2019
Bubendorf, Switzerland: –Peptide technology specialist Bachem AG is will be an exhibitor at the Middle East’s premier pharmaceutical industry expo and networking event, CPhI Middle East and Africa (MEA) in Abu Dhabi, United Arab Emirates.
The Bachem stand at Booth D85 at the Abu Dhabi National Exhibition Centre will showcase its extensive portfolio of generic peptide APIs, custom peptide and contract manufacturing (CMO) capabilities, based on its outstanding knowledge of peptide and carbohydrate chemistry.
Pioneering Partner for Peptides
The Bachem team, led by Dr. Sergey Malashikhin, Group Leader Generics Sales, will be emphasizing the comprehensive solutions for generic peptide APIs they can deliver as part of the ‘Pioneering Partner for Peptides’ mission.
Returning to CPhI MEA will provide Bachem with an ideal opportunity to showcase its capabilities as a CMO for the fast-growing industry across the Mideast and Africa, addressing an audience that includes representatives from almost 70 nations.
The Bachem Group is the world’s only full service provider of peptides and provides a full range of other services to the pharma and biotech industries.
Under its banner Pioneering Partner for Peptides, Bachem specializes in the process development and manufacture of peptides and complex organic molecules as active pharmaceutical ingredients (APIs).
A comprehensive catalog of innovative biochemicals for research and exclusive custom syntheses for research labs complete its service portfolio.
Headquartered in Switzerland with subsidiaries in Europe, the US and Asia, the group has a global reach and shows total commitment to quality, innovation and partnership to its customers worldwide.
Bachem prioritizes continuous investment in R&D on chemistries and technologies as crucial for future success. Its ever-increasing knowledge of complex proteins and peptides derives from ongoing research in proteomics, as well as progress in mass spectrometry, synthesis and ligation technologies, complemented by collaboration with external research institutions.
Bachem has six production sites in the U.S. and in Europe along with research level production and full cGMP manufacturing facilities on both continents. These provide capacity to produce APIs, key intermediates, small molecule generics and new chemical entities (NCEs).
About CPhI MEA 2019
CPhI Middle East & Africa (CPhI MEA) is one of the family of high profile pharma trade shows created by UBM Live.
CPhI MEA 2019 is a three-day event opening September 16 at the Abu Dhabi National Exhibition Center (ADNEC) in the United Arab Emirates.
The event, focusing on ingredients, is co-located with four other exhibitions, ICSE (outsourcing), FDF (dosage supply chain), P-MEC (machinery and equipment), and InnoPack (packaging and delivery).
Together they form the pharma industry’s leading regional exhibition for innovation, networking, and business, expected to attract almost 5,000 visitors from across the region along with almost 300 exhibitors.
The event is organized by Informa Markets with further information at: https://www.cphi.com/mea/.
Dr. Martina Diekmann, Vice-President, Global Marketing, Bachem Group
Tel: +41 799 459 107